- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Type 2 Diabetes Mellitus With Periodontal Complication in South Africa
Total 912 results
-
XOMA (US) LLCCompletedType 2 Diabetes MellitusUnited States
-
Eli Lilly and CompanyCompletedDiabetes Mellitus Type 2Korea, Republic of, Hungary, United States, Mexico, Argentina, India, Poland, Taiwan, Spain
-
SanofiCompletedDiabetes Mellitus Type 2United States, Austria, Canada, France, Germany, Greece, Guatemala, India, Mexico, Peru, Puerto Rico, Romania, Turkey
-
SanofiCompletedType 2 DiabetesAustralia, Denmark, South Africa, Spain, Belgium, Russian Federation, Canada, Estonia, Hungary, Latvia, Mexico, United States, Chile, Czech Republic, France, Germany, Italy, Lithuania, Poland, Romania, Sweden, Ukraine, United Kingdom
-
PhenomixTerminatedType 2 Diabetes MellitusUnited States, Argentina, Canada, Mexico, India
-
SanofiPopulation Health Research InstituteCompletedDiabetes Mellitus, Non-Insulin-DependentUnited States, France, Brazil, Poland, Romania, Germany, Italy, Netherlands, Spain, Sweden, Switzerland, Turkey, India, Philippines, Russian Federation, Slovakia, Mexico, Argentina, Croatia, Austria, Denmark, Finland, Hungary, Lithuania, Norw... and more
-
PhenomixForest LaboratoriesTerminatedType 2 Diabetes MellitusUnited States, Argentina, Chile, Czech Republic, India, Peru, Poland
-
AstraZenecaCompletedType 2 DiabetesUnited States, Canada, France, Mexico
-
Novo Nordisk A/SRecruitingType 2 DiabetesUnited States, Taiwan, Australia, Hungary, Germany, India, Canada, Spain, Czechia, Argentina, Poland, Colombia, South Africa, France, Greece, Romania
-
Eli Lilly and CompanyRecruitingDiabetes Type 2United States, India, Mexico, Puerto Rico
-
Intarcia TherapeuticsTerminatedType 2 DiabetesUnited States
-
CymaBay Therapeutics, Inc.CompletedType 2 DiabetesUnited States, Israel, Argentina, India
-
PfizerCompletedDiabetes Mellitus, Type 2United States
-
Intarcia TherapeuticsCompleted
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Australia, Hong Kong, Colombia, Russian Federation, Germany, Hungary, Italy, Mexico, Peru, Romania, Slovakia, Brazil, El Salvador
-
University of SydneyNational Health and Medical Research Council, Australia; Mylan Pharmaceuticals... and other collaboratorsRecruitingDiabetic Retinopathy | Diabetic Nephropathies | Type 1 Diabetes MellitusAustralia, Hong Kong, New Zealand, United Kingdom
-
Daiichi Sankyo, Inc.CompletedType 2 DiabetesUnited States, Peru, Mexico
-
AstraZenecaParexel; PRA Health Sciences; Q2 Solutions; Covance Laboratories, IncCompletedType 2 DiabetesUnited States, Israel, Hungary, Russian Federation, Mexico, Romania, United Kingdom
-
TakedaCompletedDiabetes Mellitus, Type 2United States, Mexico, Guatemala
-
Akros Pharma Inc.CompletedType 2 Diabetes MellitusUnited States
-
AstraZenecaTerminatedType 2 DiabetesBrazil, France, Russian Federation, South Africa, Germany, Malaysia, Finland, Norway, Hong Kong, Canada, Hungary, Portugal, Taiwan, India, Philippines, Switzerland, Indonesia, Singapore
-
GlaxoSmithKlineDuke Clinical Research InstituteCompletedDiabetes MellitusUnited States, Argentina, Germany, Poland, Russian Federation, Spain, Taiwan, Czechia, Hungary, Italy, Ukraine, Belgium, Netherlands, South Africa, Sweden, Thailand, Korea, Republic of, Mexico, Bulgaria, Hong Kong, Peru, Philippines, Gree... and more
-
Lexicon PharmaceuticalsSanofiCompletedType 2 Diabetes MellitusUnited States, Bulgaria, Canada, Czechia, France, Hungary, Slovakia, United Kingdom
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIndia, Israel, Malaysia, South Africa, Algeria, Lebanon, United Arab Emirates
-
AstraZenecaTerminatedType 2 DiabetesUnited States, Brazil, Czech Republic, Italy, Korea, Republic of, Russian Federation, South Africa, United Kingdom, Vietnam, Philippines, Malaysia, Estonia, Latvia, Lithuania, Poland, Finland, Canada, Hong Kong, Argentina, Hun... and more
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Australia, Belgium, Hong Kong, United States, Germany, Portugal, Russian Federation, France, Canada, Finland, Austria, New Zealand, Spain, Poland, Thailand, Italy, Serbia, Korea, Republic of, Hungary, Mexico, Greece, Puerto Rico, Gu... and more
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Russian Federation, Spain, Hungary, Mexico, Argentina, Slovakia, Greece, South Africa, Australia
-
PhaseBio Pharmaceuticals Inc.Completed
-
Lexicon PharmaceuticalsSanofiTerminatedHeart Failure | Type 2 Diabetes MellitusBelgium, Canada, Israel, Spain, Germany, Argentina, Chile, Hungary, Korea, Republic of, Latvia, Lithuania, Russian Federation, Sweden, Romania, Poland, Brazil, Denmark, United States, Australia, Austria, Czechia, Finland, France, Greece, Ita... and more
-
PfizerCompletedDiabetes Mellitus, Type 2 | NIDDMUnited States
-
Medical University of South CarolinaWeight Watchers InternationalCompletedObesity | Overweight | Type 2 DiabetesUnited States
-
Elcelyx Therapeutics, Inc.CompletedType 2 Diabetes MellitusUnited States, Puerto Rico
-
Eli Lilly and CompanyCompletedType 2 DiabetesUnited States, Puerto Rico, Australia, United Kingdom, Mexico, Argentina, Brazil, Israel, Canada
-
Lexicon PharmaceuticalsSanofiCompletedType 2 Diabetes MellitusUnited States, Bulgaria, Canada, Czechia, France, Italy, Latvia, Mexico, Russian Federation, Slovakia, Spain, United Kingdom
-
Daiichi Sankyo, Inc.CompletedType 2 DiabetesUnited States
-
AstraZenecaCompletedType 2 DiabetesUnited States, Canada, Mexico, Russian Federation, Romania, Poland, Czech Republic, Puerto Rico, Hungary
-
Lexicon PharmaceuticalsSanofiCompletedType 2 Diabetes MellitusUnited States, Bulgaria, Hungary, Slovakia
-
Janssen Research & Development, LLCThe George Institute for Global Health, AustraliaCompletedDiabetes Mellitus, Type 2 | Diabetic NephropathyUnited States, Canada, France, Germany, Poland, Ukraine, United Kingdom, China, Taiwan, Spain, Argentina, Colombia, Mexico, Bulgaria, India, Malaysia, Romania, Serbia, South Africa, Japan, Australia, Korea, Republic of, Chile, New Zealand and more
-
Daiichi Sankyo, Inc.CompletedType 2 DiabetesUnited States, Peru, Mexico
-
Daiichi Sankyo, Inc.CompletedType 2 DiabetesUnited States, Peru, Mexico
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes MellitusSweden, United States, Australia, Brazil, Czech Republic, Italy, Mexico, Peru, Poland, Russian Federation, South Africa, Spain, United Kingdom, Germany, China, Hungary, Netherlands, Canada, Hong Kong, Argentina, Chile, France, Israel, Puerto Rico and more
-
SanofiCompletedType 2 DiabetesUnited States, Australia, Canada, Chile, Czech Republic, Denmark, Estonia, Hungary, Lithuania, Mexico, Netherlands, Poland, Romania, Russian Federation, Slovakia, Spain, Sweden, Ukraine
-
Intarcia TherapeuticsCompletedType 2 DiabetesUnited States
-
TakedaEli Lilly and CompanyCompletedDiabetes MellitusUnited States
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesUnited States, Canada, Mexico, Russian Federation
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesMexico, United States, Argentina, Brazil, Canada
-
Eli Lilly and CompanyRecruitingType 2 DiabetesTaiwan, United States, China, Mexico, Germany, Poland
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Canada, Poland, South Africa, Slovakia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Russian Federation, United Kingdom, Denmark, Netherlands, Norway, South Africa, Finland, France, Spain, Former Serbia and Montenegro, Sweden